Inovio Pharmaceuticals INO
NASDAQ INO
$0.84 +0.04 (+5.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Inovio Pharmaceuticals (INO) Non-Current Debt (2019 - 2024)

Updated

Analysis

Inovio Pharmaceuticals (INO) Non-Current Debt (2019 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 35.80 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 62.48 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 23.68 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 23.83 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 60.50 Bn
10 Inovio Pharmaceuticals 68.56 Mn -115.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -16.42 Mn
Jun 30, 2020 171,620.00
Dec 31, 2019 4.02 Mn
Sep 30, 2019 17.77 Mn
Mar 31, 2019 75.66 Mn
API Access

Inovio Pharmaceuticals Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=INO&period=max&api_key=YOUR_API_KEY